BREYANZI has significant market potential due to its innovative approach as a CD19-directed chimeric antigen receptor (CAR) T-cell therapy. The growing prevalence of hematologic malignancies ...

DelveInsight's 'BREYANZI Market Size, Forecast, and Market Insight Report' highlights the details around BREYANZI, a CD19-directed CAR ...

In a preclinical study, researchers at Children's Hospital of Philadelphia (CHOP) demonstrated a novel gene therapy with potentially increased effectiveness and safety for the treatment for ...

FDA has provided input on key elements of the SER-155 allo-HSCT clinical development plans including support for the proposed primary efficacy ...

Now, he is trying to raise £45,500 for haematopoietic stem cell transplantation (HSCT), a high-risk treatment that aims to "reset" the immune system by destroying it and regrowing it using stem ...

When Mr. Kristof’s friend Drew sought prison for treatment, he was desperate for help. Jail just happened to be the option in front of him. This illustrates just how out of reach addiction ...

AlloHeme test accurately predicts relapse post-allo-HSCT in AML and MDS, with a median lead time of 36 days. The ACROBAT study involved 287 patients, showing significant predictive value of ...

The FDA granted orphan designation to Sanofi (SNY) US Services’ rilzabrutinib as a treatment of autoimmune hemolytic anemia, according to a post to the agency’s website. Published first on ...

The £50,000 was duly raised, and Rayanne flew off to Mexico hoping that the revolutionary HSCT treatment which uses stem cells, would help regain her life away from MS. As she explains, the treatment ...

The Green Party's new logo is an emoji. The federal party unveiled its new brand, a green dot, on Tuesday on Parliament Hill, possibly weeks before a snap federal election. "The great thing about ...